American Vanguard Corporation Total Liabilities
American Vanguard Corporation total liabilities. Based on the latest financial reports, American Vanguard Corporation (AVD) has total liabilities worth $475.62 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of American Vanguard Corporation to evaluate the company's liquid asset resilience ratio.
Total Liabilities of American Vanguard Corporation (1986–2025)
Total liabilities of American Vanguard Corporation from 1986 to 2025. This chart illustrates how American Vanguard Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of American Vanguard Corporation to see how much of total assets are deployed in long-term investments.
American Vanguard Corporation Competitors by Total Liabilities
The table below lists competitors of American Vanguard Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BG T&A Co
KQ:046310
|
Korea | ₩27.01 Billion |
|
Sangamo Therapeutics Inc
NASDAQ:SGMO
|
USA | $82.40 Million |
|
Arena Bilgisayar Sanayi ve Ticaret AS
IS:ARENA
|
Turkey | TL11.85 Billion |
|
Yeou Yih Steel Co Ltd
TWO:9962
|
Taiwan | NT$385.65 Million |
|
Creative Realities Inc
NASDAQ:CREX
|
USA | $95.30 Million |
|
Culico Metals Inc.
V:CLCO
|
Canada | CA$926.48K |
|
Nsys Co. Ltd.
KQ:333620
|
Korea | ₩34.37 Billion |
|
Mestron Holdings
KLSE:0207
|
Malaysia | RM62.94 Million |
Liability Composition Analysis (1986–2025)
This chart breaks down American Vanguard Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see American Vanguard Corporation (AVD) total assets.
Liquidity & Leverage Metrics
American Vanguard Corporation Total Liabilities Ratios Explained
American Vanguard Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how American Vanguard Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for American Vanguard Corporation (1986–2025)
The table below shows the annual total liabilities of American Vanguard Corporation from 1986 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $404.14 Million | +0.13% |
| 2024-12-31 | $403.61 Million | +1.53% |
| 2023-12-31 | $397.54 Million | +11.56% |
| 2022-12-31 | $356.33 Million | +10.86% |
| 2021-12-31 | $321.42 Million | +0.58% |
| 2020-12-31 | $319.56 Million | -7.89% |
| 2019-12-31 | $346.93 Million | +31.24% |
| 2018-12-31 | $264.36 Million | +14.80% |
| 2017-12-31 | $230.28 Million | +56.02% |
| 2016-12-31 | $147.60 Million | -15.76% |
| 2015-12-31 | $175.21 Million | -17.42% |
| 2014-12-31 | $212.17 Million | +11.87% |
| 2013-12-31 | $189.65 Million | +8.71% |
| 2012-12-31 | $174.45 Million | +14.72% |
| 2011-12-31 | $152.07 Million | +31.82% |
| 2010-12-31 | $115.36 Million | +13.52% |
| 2009-12-31 | $101.62 Million | -22.42% |
| 2008-12-31 | $130.99 Million | +20.35% |
| 2007-12-31 | $108.84 Million | -23.08% |
| 2006-12-31 | $141.50 Million | +40.41% |
| 2005-12-31 | $100.78 Million | +72.64% |
| 2004-12-31 | $58.37 Million | +3.50% |
| 2003-12-31 | $56.40 Million | +60.20% |
| 2002-12-31 | $35.20 Million | +1.73% |
| 2001-12-31 | $34.61 Million | -5.97% |
| 2000-12-31 | $36.80 Million | +24.72% |
| 1999-12-31 | $29.51 Million | -17.34% |
| 1998-12-31 | $35.70 Million | +5.31% |
| 1997-12-31 | $33.90 Million | +18.53% |
| 1996-12-31 | $28.60 Million | +34.27% |
| 1995-12-31 | $21.30 Million | -17.44% |
| 1994-12-31 | $25.80 Million | +14.67% |
| 1993-12-31 | $22.50 Million | +4.17% |
| 1992-12-31 | $21.60 Million | -3.57% |
| 1991-12-31 | $22.40 Million | +10.34% |
| 1990-12-31 | $20.30 Million | +86.24% |
| 1989-12-31 | $10.90 Million | +39.74% |
| 1988-12-31 | $7.80 Million | +11.43% |
| 1987-12-31 | $7.00 Million | +22.81% |
| 1986-12-31 | $5.70 Million | -- |
About American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection… Read more